Impax at a Glance

Welcome to our Media Center

Our Mission - To be a leader in the development, manufacturing and marketing of generic and branded pharmaceuticals utilizing our formulation expertise and unique drug delivery technologies, focusing on opportunities that increase shareholder value and provide long-term profitable growth.

Corporate Fact Sheet

• Founded – Impax Laboratories was formed in December 1999 through the merger of publicly traded Global Pharmaceuticals and privately held Impax Pharmaceuticals.
• Headquarters – Hayward, CA
• Chairman – Robert R. Burr
• President & CEO – Larry Hsu, Ph.D.
• Employees – Approximately 900
• 2010 Revenue - $879.5 million
• Approved ANDAs (Abbreviated New Drug Applications) – 66
• Stock exchange listing – Nasdaq: IPXL

Primary Businesses

Global Pharmaceuticals (generics division)
Impax Pharmaceuticals (brand division)

Media Contact

Mark Donohue
Sr. Director, Investor Relations and Corporate Communications
121 New Britain Blvd
Chalfont, PA 18914
215-558-4526